Rejuvenation Biotechnology Conference 2014
April 14, 2014
SENS Research Foundation is proud to present the Rejuvenation Biotechnology Conference: Emerging Regenerative Medicine Solutions for the Diseases of Aging. This conference will bring together leaders from the Alzheimer’s, cardiovascular, cancer, and other age-related disease communities to discuss preventative and combinatorial strategies to address the diseases of old age.
The Rejuvenation Biotechnology Conference builds upon novel strategies being pioneered by the Alzheimer’s and cancer communities. By convening the foremost leaders from academia, industry, investment, policy, and disease advocacy, SRF seeks to inspire consideration of the wider potential of these strategies and evaluate the feasibility of preventative and combinatorial medicine applications to treat all aging-related diseases. Through a series of presentations and panel discussions, Alzheimer’s disease, cancer, cardiovascular disease, diabetes, macular degeneration, musculoskeletal disease and Parkinson’s disease will be examined with scientific, economic, regulatory and other considerations in mind.
Confirmed Speakers
- Richard Barker
Director
CASMI - Maria Blasco
Vice Director
Spanish National Cancer Research Centre - Judith Campisi
Professor
Buck Institute for Research on Aging - George Church
Professor of Genetics
Harvard Medical School
Professor of Health Sciences and Technology
Harvard and MIT - Laura Esserman
Professor, Departments of Surgery and Radiology, and Affiliate Faculty, Institute for Health Policy Studies
Director, Carol Franc Buck Breast Care Center; Co-Leader, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco - Caleb Finch
ARCO/Kieschnick Professor of Gerontology and Biological Science and University Professor
USC Davis School of Gerontology - Claudia Gravekamp
Associate Professor
Albert Einstein College of Medicine - W. Gray Jerome
Associate Professor and Director, Graduate Program in Cellular and Molecular Pathology
Vanderbilt University Medical Center - Jeffrey Karp
Associate Professor
Harvard Medical School
Co-Director of the Center for Regenerative Therapeutics
Brigham and Women’s Hospital - Jeanne Loring
Professor
Scripps Research Institute - Stephen Minger
Chief Scientist, Cellular Sciences
GE Healthcare Life Sciences, UK - Brock Reeve
Executive Director
Harvard Stem Cell Institute - David Schaffer
Professor
University of California Berkeley
Director
Berkeley Stem Cell Center - Evan Snyder
Professor
Sanford/Burnham Medical Research Institute - Matthias Steger
Global Head, Research & Technology Partnering
Hoffmann-La Roche - Michael West
CEO
Biotime, Inc.